Descriptor English: | Synucleinopathies | ||||||
Descriptor Spanish: |
Sinucleinopatías
| ||||||
Descriptor Portuguese: | Sinucleinopatias | ||||||
Descriptor French: | Synucléinopathies | ||||||
Entry term(s): |
Synucleinopathy a-Synucleinopathies a-Synucleinopathy alpha Synuclein Pathologies alpha Synuclein Pathology alpha Synucleinopathies alpha-Synucleinopathies alpha-Synucleinopathy |
||||||
Tree number(s): |
C10.574.928 C18.452.845.650 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000080874 | ||||||
Scope note: | Neurodegenerative disorders involving deposition of abnormal ALPHA-SYNUCLEIN in dopaminergic neurons and glial cells in the brain. Pathological aggregations of alpha-synuclein proteins results in LEWY BODIES and Lewy neurites; melanin granules in the SUBSTANTIA NIGRA and LOCUS COERULEUS; and glial cytoplasmic inclusions. Synucleinopathies are associated with mutation in the ALPHA-SYNUCLEIN (SNCA) gene on chromosome 4. PARKINSON DISEASE; LEWY BODY DISEASE with dementia; and MULTIPLE SYSTEM ATROPHY are prominent examples of synucleinopathy. |
||||||
Allowable Qualifiers: |
BL blood CF cerebrospinal fluid CI chemically induced CL classification CN congenital CO complications DG diagnostic imaging DH diet therapy DI diagnosis DT drug therapy EC economics EH ethnology EM embryology EN enzymology EP epidemiology ET etiology GE genetics HI history IM immunology ME metabolism MI microbiology MO mortality NU nursing PA pathology PC prevention & control PP physiopathology PS parasitology PX psychology RH rehabilitation RT radiotherapy SU surgery TH therapy UR urine VE veterinary VI virology |
||||||
Previous Indexing: |
Neurodegenerative Diseases (1998-2019) alpha-Synuclein (1999-2019) |
||||||
Public MeSH Note: | 2020 |
||||||
History Note: | 2020 |
||||||
Related: |
Lewy Bodies
MeSH alpha-Synuclein MeSH | ||||||
DeCS ID: | 59254 | ||||||
Unique ID: | D000080874 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 2020/01/01 | ||||||
Date of Entry: | 2019/07/08 | ||||||
Revision Date: | 2019/05/17 |
|
Synucleinopathies
- Preferred
Concept UI |
M000648557 |
Scope note | Neurodegenerative disorders involving deposition of abnormal ALPHA-SYNUCLEIN in dopaminergic neurons and glial cells in the brain. Pathological aggregations of alpha-synuclein proteins results in LEWY BODIES and Lewy neurites; melanin granules in the SUBSTANTIA NIGRA and LOCUS COERULEUS; and glial cytoplasmic inclusions. Synucleinopathies are associated with mutation in the ALPHA-SYNUCLEIN (SNCA) gene on chromosome 4. PARKINSON DISEASE; LEWY BODY DISEASE with dementia; and MULTIPLE SYSTEM ATROPHY are prominent examples of synucleinopathy. |
Preferred term | Synucleinopathies |
Entry term(s) |
Synucleinopathy a-Synucleinopathies a-Synucleinopathy alpha Synuclein Pathologies alpha Synuclein Pathology alpha Synucleinopathies alpha-Synucleinopathies alpha-Synucleinopathy |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey